Compare EFSC & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EFSC | NEOG |
|---|---|---|
| Founded | 1988 | 1981 |
| Country | United States | United States |
| Employees | 1418 | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | N/A | 1995 |
| Metric | EFSC | NEOG |
|---|---|---|
| Price | $61.04 | $8.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $66.33 | $10.67 |
| AVG Volume (30 Days) | 187.1K | ★ 2.5M |
| Earning Date | 04-22-2026 | 04-09-2026 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $894,661,000.00 |
| Revenue This Year | $14.22 | N/A |
| Revenue Next Year | $3.77 | N/A |
| P/E Ratio | ★ $11.50 | $456.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $51.18 | $4.56 |
| 52 Week High | $62.20 | $11.43 |
| Indicator | EFSC | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 49.41 |
| Support Level | $56.76 | $8.21 |
| Resistance Level | $61.79 | $9.49 |
| Average True Range (ATR) | 1.51 | 0.36 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 84.78 | 59.46 |
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Its Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.